BofA downgraded Graphite Bio to Underperform from Neutral with a price target of $2, down from $3.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on GRPH:
- Cowen downgrades Graphite Bio on ‘uncertain strategy’ after update
- Graphite Bio downgraded to Market Perform from Outperform at Cowen
- Graphite Bio to explore strategic alternatives, cuts staff by 50%
- Graphite Bio downgraded to Neutral from Buy at BTIG
- Graphite Bio downgraded to Neutral from Buy at BofA